Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3.
Andrew BlauveltMelinda J GooderhamNeal BhatiaRichard G LangleyShannon SchneiderJohn ZoidisAzra KurbasicApril ArmstrongJonathan Ian SilverbergPublished in: Dermatology and therapy (2022)
NCT03131648 (registered 27-Apr-2017); NCT03160885 (registered 19-May-2017); NCT03363854 (registered 6-Dec-2017).
Keyphrases